How much does a box of Mobotinib cost now?

Mobocertinib (Mobocertinib) is a targeted therapy drug mainly used to treat EGFR mutated non-small cell lung cancer (NSCLC). The drug is already on the market in China, but because it has not yet been included in medical insurance, patients may face certain difficulties in purchasing it directly.

At present, Mobotinib is already on the market in the country, but it is not included in the medical insurance system. Therefore, patients usually need to purchase them through hospital pharmacies, and the price is higher. According to market conditions, the domestic price of the original drug of Mobotinib is approximately RMB 7,000 to RMB 8,000 per box, and the specific price may fluctuate. Since the drug is not covered by medical insurance, patients need to bear the entire cost, which may be a considerable burden for some patients. Therefore, patients need to understand and consult the specific prices of local hospital pharmacies in advance when purchasing.

The price of the original drug of Mobotinib is relatively high overseas. Taking the Hong Kong version and Japan's Takeda version as examples, the price of the original drug is roughly between 7,000 and 8,000 yuan. Drugs in overseas markets are usually more expensive, especially original drugs, with large price fluctuations. In addition, when patients purchase through overseas channels, they may also need to pay customs duties and shipping fees, further increasing the overall cost of the drug. Therefore, some patients may choose to purchase generic drugs as an alternative.

Compared with the original drug, the price of generic drugs of Mobotinib is more affordable, especially the generic drugs produced in Laos. The price of the Lao version of Mobotinib is about 3,000 yuan, which is about half cheaper than the original drug. For patients, choosing generic drugs can greatly reduce the financial burden. Moreover, the ingredients of the Lao version of generic drugs are basically the same as those of the original drugs, and their efficacy and safety have also undergone strict quality control, allowing patients to achieve a balance between economics and therapeutic effects.

Since Mobotinib has not yet been included in medical insurance in China, domestic patients need to purchase it through a hospital or pharmacy. Considering the high price of medicines, some patients may choose to purchase them through overseas channels, such as pharmacies in Hong Kong or other countries. However, overseas purchases may involve more complicated procedures and high logistics costs, so patients should be cautious when choosing purchasing channels, and it is best to make decisions under the guidance of a doctor. At the same time, patients should understand the situation of generic drugs and choose appropriate drugs for treatment to ensure therapeutic efficacy and safety.

References：https://en.wikipedia.org/wiki/Mobocertinib